2023 Specialty Day Access Pass-Biologics for Chronic Tendinopathy

Video Transcription

Video Summary

Jason Jagoo from the University of Colorado discusses tendinopathy, revealing that affected tendon cells lose the ability to produce and respond to their environment, shifting to an inflammatory state due to genetic alterations. Traditional treatments like PRP show limited success, as they don't reverse these cellular changes. Bone marrow aspirate concentrate (BMAC) shows promise in restoring cell function and tendon structure, though results vary by patient. In cases where biologics are insufficient, surgical approaches, including arthroscopy and tendon scraping, may be needed. Overall, tendinopathy remains challenging, with future therapies potentially focusing on optimized biologic dosing and tailored interventions.

Asset Caption

Jason L. Dragoo, M.D., FAANA

Keywords

tendinopathy

inflammatory state

PRP treatment

bone marrow aspirate concentrate

surgical interventions